Biomatics Capital Partners
Biomatics Capital is a healthcare-focused venture firm that invests in companies at the intersection of genomics and digital data. The firm supports companies across areas including gene editing and DNA synthesis and positions itself as an active partner providing capital, strategic advising and connections to domain experts.
Biomatics Capital Partners
Seattle, Washington, United States, North America
Services
Equity investments via healthcare venture funds
Provides capital to healthcare and biotech companies through firm-managed funds (multiple funds referenced).
Strategic advising and execution support
Advises portfolio companies on strategy and execution across biotechnology domains (stated experience spans gene editing to DNA synthesis).
Network and expert introductions
Connects entrepreneurs to a network of experts and partners to support company development.
Investor relations / LP portal
Maintains an investor portal for limited partners.
Equity investments via healthcare venture funds
Provides capital to healthcare and biotech companies through firm-managed funds (multiple funds referenced).
Strategic advising and execution support
Advises portfolio companies on strategy and execution across biotechnology domains (stated experience spans gene editing to DNA synthesis).
Network and expert introductions
Connects entrepreneurs to a network of experts and partners to support company development.
Investor relations / LP portal
Maintains an investor portal for limited partners.
Portfolio
Referenced on Biomatics homepage and in multiple portfolio media coverage entries about DNA data storage and sequencing.
#DNA synthesis / synthetic biology
Covered in press items including a reported acquisition by Exact Sciences (press coverage listed on site).
#Liquid biopsy / diagnostics
Multiple media stories listed on Biomatics site covering AI in healthcare and medication adherence studies.
#AI-enabled digital health / medication adherence
Press coverage includes clinical progress and funding announcements (listed on site).
#Neurobehavioral therapeutics / neuroscience
Multiple media items covering financing and technology noted on the site.
#Antibody discovery / biotechnology
Press coverage on a dermal microcoring device and clinical outcomes listed on the site.
#Dermatology / medical device
Referenced on Biomatics homepage and in multiple portfolio media coverage entries about DNA data storage and sequencing.
#DNA synthesis / synthetic biology
Covered in press items including a reported acquisition by Exact Sciences (press coverage listed on site).
#Liquid biopsy / diagnostics
Multiple media stories listed on Biomatics site covering AI in healthcare and medication adherence studies.
#AI-enabled digital health / medication adherence
Press coverage includes clinical progress and funding announcements (listed on site).
#Neurobehavioral therapeutics / neuroscience
Multiple media items covering financing and technology noted on the site.
#Antibody discovery / biotechnology
Press coverage on a dermal microcoring device and clinical outcomes listed on the site.
#Dermatology / medical device